BioSpace News Archive

Genetown

Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform

Beaconcure, Inc., the leading clinical data technology and automation company, announced the closing of its $14 million Series B financing round.

June 13, 2023
·
4 min read
Business

HSS Appoints Mary E. Cassai, RN to Executive Vice President, Chief Operating Officer

Hospital for Special Surgery announced the appointment of Mary E. Cassai, MPA, BSN, RN, NEA-BC, to Executive Vice President and Chief Operating Officer, following a nationwide search.

June 13, 2023
·
5 min read
Heligenics Unveils A First-Of-Its-Kind Precision Prescription Test For Breast Cancer Therapeutics

Heligenics, a cutting-edge biotech company, announces a first-of-its-kind precision genetic test to select among drugs to treat breast cancer.

June 13, 2023
·
2 min read
Biotech Bay

Danish National Genome Center selects QIAGEN for variant interpretation in oncology genome sequencing

QIAGEN announced that its variant interpretation and reporting software, QIAGEN Clinical Insight Interpret, is being deployed as a part of a national initiative in Denmark to offer sequencing-based solutions for cancer patients.

June 13, 2023
·
6 min read
Biotech Beach

Kura Oncology Announces Commencement of Public Offering of Common Stock and Pre-Funded Warrants

Kura Oncology, Inc. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell $100,000,000 of shares of its common stock.

June 13, 2023
·
5 min read
BioMidwest

Centene Corporation Completes Divestiture of Apixio

Centene Corporation announced it has completed the previously announced divestiture of Apixio, a leading artificial intelligence platform that enables value-based care, to New Mountain Capital.

June 13, 2023
·
8 min read
Lone Star Bio

McKesson Corporation Announces Pricing Terms of Tender Offer for Any and All 3.796% Notes Due 2024

McKesson Corporation announced the pricing terms of its previously announced offer to purchase for cash any and all of its outstanding 3.796% Notes due 2024.

June 13, 2023
·
7 min read
Drug Development

Acadia Pharmaceuticals Announces Phase 3 Development Candidate ACP-101 (intranasal carbetocin) for Prader-Willi Syndrome

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the addition of a new Phase 3 development candidate to its rare disease portfolio, ACP-101 (intranasal carbetocin), for the treatment of hyperphagia (a false and unrelenting state of starvation) in Prader-Willi syndrome (PWS).

June 13, 2023
·
7 min read
Biotech Beach

Dermata Therapeutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET

Dermata Therapeutics, Inc. announced that Dermata’s CEO, Gerald Proehl, has been invited to present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET.

June 13, 2023
·
3 min read
Business

Baxter to Host Second-Quarter 2023 Financial Results Conference Call for Investors

Baxter International Inc., a global medtech leader, will host a conference call to discuss its second-quarter 2023 financial results on Thursday, July 27, 2023 at 7:30 a.m. Central Time.

June 13, 2023
·
1 min read